B+
Bull case
20%
Probability
Target price
$175.00
Analysis reference price unavailable
Analysis 2026-02-20 · RankAlpha Sentiment AI
GH
Guardant HealthFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment AIMost likely
B
Base case
60%
Probability
Target price
$113.84
Analysis reference price unavailable
Analysis 2026-02-20 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$55.00
Analysis reference price unavailable
Analysis 2026-02-20 · RankAlpha Sentiment AI
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-02-20
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+26.8
Score
AI commentary
Sentiment is mixed — analyst targets cluster near the median while the high/low spread is wide, reflecting disagreement on reimbursement and adoption. Near-term focus: results and payer updates; long-term view depends on commercial traction and regulatory clarity.
RankAlpha Sentiment AI - 2026-02-20
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-21catalystNext quarterly results / revenue updateHigh impact
Quarterly results may revise revenue guidance and near-term visibility; market reaction likely focused on diagnostic volumes and margin commentary.
2026-09-30eventClinical readout or regulatory decision for new indicationHigh impact
Binary clinical/regulatory outcomes may drive large re-rating; date provided as planning-window end per event-rule.
2027-02-20catalystBroader commercial adoption and payer coverageHigh impact
Expanded payer coverage and international rollout could materially lift recurring revenue over the long horizon; timing assumed per long-window rule.
Recommendation
N/A
No formal recommendation provided.
As of 2026-02-20 • Updated nightlySource: Internal modelMethodology